Overview A Phase 1, First Time in Humans Study of NST-1024 Status: Recruiting Trial end date: 2021-12-30 Target enrollment: Participant gender: Summary A first time in man study of NST-1024 Phase: Phase 1 Details Lead Sponsor: NorthSea Therapeutics B.V.